4.7 Article

hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Effect of Glucose on 3D Cardiac Microtissues Derived from Human Induced Pluripotent Stem Cells

Michael Balistreri et al.

PEDIATRIC CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Extracellular Matrix-Mediated Maturation of Human Pluripotent Stem Cell-Derived Cardiac Monolayer Structure and Electrophysiological Function

Todd J. Herron et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2016)

Article Biotechnology & Applied Microbiology

Evolution of strategies to improve preclinical cardiac safety testing

Gary Gintant et al.

NATURE REVIEWS DRUG DISCOVERY (2016)

Article Pharmacology & Pharmacy

The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative Update on progress

Thomas Colatsky et al.

JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)

Article Cardiac & Cardiovascular Systems

Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium

Philip T. Sager et al.

AMERICAN HEART JOURNAL (2014)

Review Cardiac & Cardiovascular Systems

Engineering Adolescence Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes

Xiulan Yang et al.

CIRCULATION RESEARCH (2014)

Article Pharmacology & Pharmacy

Fluoxetine Blocks Nav1.5 Channels via a Mechanism Similar to That of Class 1 Antiarrhythmics

Hugo Poulin et al.

MOLECULAR PHARMACOLOGY (2014)

Article Cardiac & Cardiovascular Systems

Induced Pluripotent Stem Cell-Derived Cardiomyocytes Boutique Science or Valuable Arrhythmia Model?

Bjoern C. Knollmann

CIRCULATION RESEARCH (2013)

Review Public, Environmental & Occupational Health

Dealing with Global Safety Issues Was the Response to QT-Liability of Non-Cardiac Drugs Well Coordinated?

Norman Stockbridge et al.

DRUG SAFETY (2013)

Article Biochemical Research Methods

Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes

Sara S. Nunes et al.

NATURE METHODS (2013)

Article Cell & Tissue Engineering

Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes

Alexandra Bizy et al.

STEM CELL RESEARCH (2013)

Review Cardiac & Cardiovascular Systems

Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells to Cardiomyocytes A Methods Overview

Christine L. Mummery et al.

CIRCULATION RESEARCH (2012)

Article Multidisciplinary Sciences

Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling

Xiaojun Lian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Cardiac & Cardiovascular Systems

High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents

Junyi Ma et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Growth of Engineered Human Myocardium With Mechanical Loading and Vascular Coculture

Nathaniel L. Tulloch et al.

CIRCULATION RESEARCH (2011)

Article Pharmacology & Pharmacy

Opportunities for Use of Human iPS Cells in Predictive Toxicology

B. D. Anson et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)

Article Pharmacology & Pharmacy

Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation

P Kirchhof et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)